Secondary Rhinoplasty / Orthognathic Surgery
Treatment for Orofacial clefts
Effectiveness
82%
Safety Score
65%
Clinical Trials
600
Participants
60K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
65
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate post-op, final results develop over 6-12 months
Treatment Duration
Single surgery (3-6 hours), 4-8 weeks recovery
Evidence Quality
MODERATEConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$3,000
Side Effect Mgmt:$800
Total Annual:$3,900
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$97,500/QALY
QALYs Gained
1.8
Outcome-Based Costs
Cost per Responder
$4,432
Cost per Remission
$5,200
Secondary Rhinoplasty / Orthognathic Surgery Outcomes
for Orofacial clefts
Efficacy Outcomes
Overall Effectiveness
+82%
Response Rate
+88%
Remission Rate
+75%
Common Side Effects
Swelling/Bruising
+100%
Asymmetry recurrence
+10%
Need for revision surgery
+20%
Sensory changes
+5%
Infection
+2%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov